Webinar: Orange Book listing sheets under the microscope

Allen & Overy LLP
Contact
Preparing the Orange Book listing sheet (i.e., Form FDA 3542) for a U.S. patent is more than just checking the boxes.

Generic drug companies have recently argued that statements made in those listing sheets could be used to preclude a patent owner in proving infringement; and the courts appear to be receptive to such arguments.

Listen to our discussion on recent caselaw that could implicate your Orange Book listing strategy and learn best practices and considerations to See more +

Preparing the Orange Book listing sheet (i.e., Form FDA 3542) for a U.S. patent is more than just checking the boxes.

Generic drug companies have recently argued that statements made in those listing sheets could be used to preclude a patent owner in proving infringement; and the courts appear to be receptive to such arguments.

Listen to our discussion on recent caselaw that could implicate your Orange Book listing strategy and learn best practices and considerations to maximize the value of your pharmaceutical patents in the United States. See less -

Embed
Copy

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Allen & Overy LLP | Attorney Advertising

Written by:

Allen & Overy LLP
Contact
more
less

Allen & Overy LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide